Meropenem Cf

Meropenem, the active ingredient in Meropenem Cf, is a carbapenem antibiotic presented as an injectable solution for intravenous use. It treats severe bacterial infections such as complicated intra‑abdominal infections, complicated urinary tract infections, nosocomial pneumonia, meningitis, and severe sepsis in hospitalized patients.

GNH USA supplies Meropenem Cf as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Meropenem is a broad‑spectrum carbapenem antibiotic used for serious bacterial infections. - Complicated intra‑abdominal infections: provides effective bacterial eradication in patients with intra‑abdominal sepsis. - Complicated urinary tract infections: eliminates resistant uropathogens causing severe UTIs. - Nosocomial pneumonia: treats hospital‑acquired lung infections resistant to other beta‑lactams. - Meningitis: penetrates the cerebrospinal fluid to eradicate causative bacteria. - Severe sepsis and septic shock: offers rapid bactericidal activity in critically ill patients.

Adverse reactions may occur with meropenem therapy.

Common Side Effects: - Nausea: mild to moderate gastrointestinal discomfort. - Diarrhea: may be watery and self‑limiting. - Rash: erythematous skin eruption. - Headache: transient cranial discomfort. - Infusion site reactions: pain, erythema, or phlebitis at the injection site. - Elevated liver enzymes: transient increase in transaminases.

Serious or Rare Side Effects: - Seizures: especially in patients with renal impairment or CNS disorders. - Clostridioides difficile colitis: severe diarrhea due to intestinal flora disruption. - Anaphylaxis: acute, life‑threatening hypersensitivity reaction. - Severe neutropenia: marked reduction in white blood cells. - Renal toxicity: acute kidney injury in susceptible individuals. - Hypersensitivity syndrome: systemic rash, fever, and organ involvement.

Use meropenem with careful clinical monitoring. - Renal function: adjust dose in patients with impaired renal clearance. - Allergy: avoid in individuals with known carbapenem hypersensitivity. - Pregnancy: prescribe only when benefit outweighs potential risk. - Concomitant nephrotoxic drugs: monitor renal parameters closely. - Superinfection: watch for secondary fungal or C. difficile infection. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze or shake.

Meropenem may interact with other medicines.

Major Interactions (Avoid): - Valproic acid: meropenem reduces serum valproate levels, increasing seizure risk. - Aminoglycosides: combined use may enhance nephrotoxicity. - Loop diuretics: may increase ototoxic potential when used together.

Moderate Interactions (Monitor Closely): - Warfarin: meropenem can alter INR, requiring coagulation monitoring. - Phenytoin: may increase neurotoxic effects; observe neurological status. - Corticosteroids: concurrent use may raise the chance of superinfection.